Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK.
Curr Med Res Opin. 2011 Nov;27 Suppl 3:47-55. doi: 10.1185/03007995.2011.614937.
This study investigated and compared the prevalence of microalbuminuria and overt proteinuria and their determinants in a cohort of UK resident patients of white European or south Asian ethnicity with type 2 diabetes mellitus.
A total of 1978 patients, comprising 1486 of south Asian and 492 of white European ethnicity, in 25 general practices in Coventry and Birmingham inner city areas in England were studied in a cross-sectional study. Demographic and risk factor data were collected and presence of microalbuminuria and overt proteinuria assessed.
ISRCTN 38297969.
Prevalences of microalbuminuria and overt proteinuria.
Urinary albumin:creatinine measurements were available for 1852 (94%) patients. The south Asian group had a lower prevalence of microalbuminuria, 19% vs. 23% and a higher prevalence of overt proteinuria, 8% vs. 3%, χ(2) = 15.85, 2df, P = 0.0004. In multiple logistic regression models, adjusted for confounding factors, significantly increased risk for the south Asian vs. white European patients for overt proteinuria was shown; OR (95% CI) 2.17 (1.05, 4.49), P = 0.0365. For microalbuminuria, an interaction effect for ethnicity and duration of diabetes suggested that risk for south Asian patients was lower in early years following diagnosis; OR for SA vs. WH at durations 0 and 1 year were 0.56 (0.37, 0.86) and 0.59 (0.39, 0.89) respectively. After 20 years' duration, OR = 1.40 (0.63, 3.08).
Comparability of ethnicity defined groups; statistical methods controlled for differences between groups, but residual confounding may remain. Analyses are based on a single measure of albumin:creatinine ratio.
There were significant differences between ethnicity groups in risk factor profiles and microalbuminuria and overt proteinuria outcomes. Whilst south Asian patients had no excess risk of microalbuminuria, the risk of overt proteinuria was elevated significantly, which might be explained by faster progression of renal dysfunction in patients of south Asian ethnicity.
本研究旨在调查和比较英国居住的白人欧洲裔或南亚裔 2 型糖尿病患者中微量白蛋白尿和显性蛋白尿的患病率及其决定因素。
在英格兰考文垂和伯明翰市中心的 25 家全科诊所中,对总共 1978 名患者进行了横断面研究,其中包括 1486 名南亚裔患者和 492 名白人欧洲裔患者。收集了人口统计学和危险因素数据,并评估了微量白蛋白尿和显性蛋白尿的存在情况。
ISRCTN38297969。
微量白蛋白尿和显性蛋白尿的患病率。
1852 名(94%)患者可进行尿白蛋白/肌酐测定。南亚组的微量白蛋白尿患病率较低,为 19%,而显性蛋白尿的患病率较高,为 8%,χ(2) = 15.85,2df,P = 0.0004。在调整混杂因素的多变量逻辑回归模型中,南亚组患者显性蛋白尿的风险显著高于白人欧洲裔患者;OR(95%CI)为 2.17(1.05,4.49),P = 0.0365。对于微量白蛋白尿,种族和糖尿病持续时间之间的交互效应表明,在诊断后早期,南亚患者的风险较低;南亚患者与白人欧洲裔患者的 OR(SA 与 WH)在 0 年和 1 年的比值分别为 0.56(0.37,0.86)和 0.59(0.39,0.89)。20 年后,OR = 1.40(0.63,3.08)。
按种族定义的组之间的可比性;统计方法控制了组间差异,但可能仍存在残余混杂。分析基于白蛋白/肌酐比值的单次测量。
在危险因素谱和微量白蛋白尿及显性蛋白尿结局方面,不同种族组之间存在显著差异。虽然南亚裔患者微量白蛋白尿的风险没有增加,但显性蛋白尿的风险显著升高,这可能是南亚裔患者肾功能恶化更快所致。